As the prevalence of COPD rises with age ... manual dexterity, and hand strength, the most influential factors in inhaler selection are cost reimbursement, device availability, device convenience ...
Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...
1d
ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...
Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...
Customizing inhaled therapy to meet the needs of COPD patients. Postgrad Med ... slow and deep inhalation, and hand strength to actuate), lack of dose counter on device, difficult for patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback